Capital Advantage Inc. Buys Shares of 5,087 Abbott Laboratories (NYSE:ABT)
MarketBeat
Capital Advantage Inc. bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 5,087 shares of the healthcare product maker's stock, valued at approximately $575,000. A number of other hedge funds
NYSE:ABT